Buscopan · DIN 00363812 · 10 mg · tablet
Limited Use, Reason for Use code 481 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 481 required
Write on scriptReason for Use code 481 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 481
Reason for Use code 481
For the management of patients receiving palliative care*.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
*The patient must have a progressive life-limiting illness and require this medication for palliative purposes.
1 brand, same coverage
Buscopan · DIN 00363812
Manufacturer: Sanofi Consumer Health Inc.; listing date 2020-07-31
Health Canada: Marketed since 2021-10-28 · brand BUSCOPAN · ATC A03BB01 BUTYLSCOPOLAMINE · form Tablet · route Oral · ingredients HYOSCINE BUTYLBROMIDE 10 MG · company Sanofi consumer health inc · schedule Ethical
Ministry pays: $0.2711 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00363812)
Source record
DIN 00363812: Buscopan
Raw flags: sec12=Y, sec3=Y
Item: 120800009; group id 204; item number 0373; lccId 00336; manufacturer id SCO
Source form: Tab; strength: 10mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.3655; ministry $0.2711
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00363812
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2481
Interchangeable products
Accel-Hyoscine · DIN 02512335 · $0.2711
Shortage status: resolved shortage (ended November 14, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=00363812
Shortage record checked October 6, 2026